Matthew Morris: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - "|first5=" to " | first5 = ") |
Notjusttired (talk | contribs) m (Text replacement - "|first2=" to " | first2 = ") |
||
| Line 2: | Line 2: | ||
==Research studies== | ==Research studies== | ||
*2018, High-fidelity discrete modeling of the [[HPA axis]]: a study of regulatory plasticity in biology<ref>{{Cite journal|last=Sedghamiz|first=Hooman | last2 = Morris|first2=Matthew|author-link2=Matthew Morris | last3 = Craddock|first3=Travis J. A.|author-link3=Travis Craddock | last4 = Whitley|first4=Darrell|last5=Broderick | first5 = Gordon|author-link5=Gordon Broderick|date=July 17, 2018|title=High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology|url=https://bmcsystbiol.biomedcentral.com/articles/10.1186/s12918-018-0599-1|journal=BMC Systems Biology|volume=12|issue=76|pages=|doi=10.1186/s12918-018-0599-1|via=}}</ref> [https://bmcsystbiol.biomedcentral.com/articles/10.1186/s12918-018-0599-1 (Abstract)] | *2018, High-fidelity discrete modeling of the [[HPA axis]]: a study of regulatory plasticity in biology<ref>{{Cite journal|last=Sedghamiz|first=Hooman | last2 = Morris | first2 = Matthew|author-link2=Matthew Morris | last3 = Craddock|first3=Travis J. A.|author-link3=Travis Craddock | last4 = Whitley|first4=Darrell|last5=Broderick | first5 = Gordon|author-link5=Gordon Broderick|date=July 17, 2018|title=High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology|url=https://bmcsystbiol.biomedcentral.com/articles/10.1186/s12918-018-0599-1|journal=BMC Systems Biology|volume=12|issue=76|pages=|doi=10.1186/s12918-018-0599-1|via=}}</ref> [https://bmcsystbiol.biomedcentral.com/articles/10.1186/s12918-018-0599-1 (Abstract)] | ||
*2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome<ref>{{Cite journal|last=Morris|first=Matthew C.|author-link=Matthew Morris | last10 = Fletcher | first10 = Mary Ann|author-link10=Mary Ann Fletcher | last2 = Cooney|first2=Katherine E.|author-link2= | last3 = Sedghamiz|first3=Hooman|author-link3= | last4 = Abreu|first4=Maria|author-link4=|last5=Collado | first5 = Fanny |author-link5= | last6 = Balbin | first6 = Elizabeth G.|author-link6=Elizabeth Balbin | last7 = Craddock | first7 = Travis J.A.|author-link7= | last8 = Klimas | first8 = Nancy G.|author-link8=Nancy Klimas | last9 = Broderick | first9 = Gordon|author-link9=Gordon Broderick|date=Mar 2019|title=Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0149291819301122|journal=Clinical Therapeutics|language=en|volume=|issue=|pages=|doi=10.1016/j.clinthera.2019.03.002|quote=|via=}}</ref> [https://www.sciencedirect.com/science/article/abs/pii/S0149291819301122?via%3Dihub (Abstract)] | *2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome<ref>{{Cite journal|last=Morris|first=Matthew C.|author-link=Matthew Morris | last10 = Fletcher | first10 = Mary Ann|author-link10=Mary Ann Fletcher | last2 = Cooney | first2 = Katherine E.|author-link2= | last3 = Sedghamiz|first3=Hooman|author-link3= | last4 = Abreu|first4=Maria|author-link4=|last5=Collado | first5 = Fanny |author-link5= | last6 = Balbin | first6 = Elizabeth G.|author-link6=Elizabeth Balbin | last7 = Craddock | first7 = Travis J.A.|author-link7= | last8 = Klimas | first8 = Nancy G.|author-link8=Nancy Klimas | last9 = Broderick | first9 = Gordon|author-link9=Gordon Broderick|date=Mar 2019|title=Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0149291819301122|journal=Clinical Therapeutics|language=en|volume=|issue=|pages=|doi=10.1016/j.clinthera.2019.03.002|quote=|via=}}</ref> [https://www.sciencedirect.com/science/article/abs/pii/S0149291819301122?via%3Dihub (Abstract)] | ||
*2019, Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary<ref>{{Cite journal|last=Richman|first=Spencer |author-link= | last2 = Morris|first2=Matthew C.|author-link2=Matthew Morris | last3 = Broderick|first3=Gordon|author-link3=Gordon Broderick | last4 = Craddock|first4=Travis J.A.|author-link4=|last5=Klimas | first5 = Nancy G.|author-link5=Nancy Klimas | last6 = Fletcher | first6 = Mary Ann|date=Mar 2019|title=Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary|url=https://linkinghub.elsevier.com/retrieve/pii/S0149291819300712|journal=Clinical Therapeutics|language=en|volume=|issue=|pages=|doi=10.1016/j.clinthera.2019.02.011|quote=|via=|author-link6=Mary Ann Fletcher}}</ref> [[pubmed:30871727|(Abstract)]] | *2019, Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary<ref>{{Cite journal|last=Richman|first=Spencer |author-link= | last2 = Morris | first2 = Matthew C.|author-link2=Matthew Morris | last3 = Broderick|first3=Gordon|author-link3=Gordon Broderick | last4 = Craddock|first4=Travis J.A.|author-link4=|last5=Klimas | first5 = Nancy G.|author-link5=Nancy Klimas | last6 = Fletcher | first6 = Mary Ann|date=Mar 2019|title=Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary|url=https://linkinghub.elsevier.com/retrieve/pii/S0149291819300712|journal=Clinical Therapeutics|language=en|volume=|issue=|pages=|doi=10.1016/j.clinthera.2019.02.011|quote=|via=|author-link6=Mary Ann Fletcher}}</ref> [[pubmed:30871727|(Abstract)]] | ||
==Online presence== | ==Online presence== | ||
Revision as of 18:34, October 17, 2022
Matthew C. Morris, PhD, researches at Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, US and Center for Clinical Systems Biology, Rochester General Hospital, Rochester, NY, US.
Research studies[edit | edit source]
- 2018, High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology[1] (Abstract)
- 2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome[2] (Abstract)
- 2019, Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary[3] (Abstract)
Online presence[edit | edit source]
References[edit | edit source]
- ↑ Sedghamiz, Hooman; Morris, Matthew; Craddock, Travis J. A.; Whitley, Darrell; Broderick, Gordon (July 17, 2018). "High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology". BMC Systems Biology. 12 (76). doi:10.1186/s12918-018-0599-1.
- ↑ Morris, Matthew C.; Cooney, Katherine E.; Sedghamiz, Hooman; Abreu, Maria; Collado, Fanny; Balbin, Elizabeth G.; Craddock, Travis J.A.; Klimas, Nancy G.; Broderick, Gordon; Fletcher, Mary Ann (March 2019). "Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.03.002.
- ↑ Richman, Spencer; Morris, Matthew C.; Broderick, Gordon; Craddock, Travis J.A.; Klimas, Nancy G.; Fletcher, Mary Ann (March 2019). "Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.02.011.
